PillsCard
Preparing your view…
PillsCard
Preparing your view…
Ushbu ma'lumotlar faqat ta'lim maqsadida taqdim etilgan. U tibbiy maslahat sifatida mo'ljallanmagan. Har doim malakali tibbiyot mutaxassisiga murojaat qiling.
Tavsif, Dozalash, Nojo'ya ta'sirlar, Qarshi ko'rsatmalar. Data from EMA, URPL, openFDA and other regulatory sources.
| Budesonide | Fluticasone | |
|---|---|---|
| Faol moddalar | BUDESONIDE | FLUTICASONE FUROATE |
| ATC kodi | D07AC09 | D07AC17 |
| Dori shakli | — | POWDER |
| Dozalash | — | 0.1MG/INH |
| Qo'llash usuli | — | INHALATION |
| Ishlab chiqaruvchi | — | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LTD ENGLAND |
Budesonide (INN: BUDESONIDE, ATC D07AC09) and Fluticasone (INN: FLUTICASONE FUROATE, ATC D07AC17) differ in active substance, indications, and safety profile. The table above summarizes the clinical differences from regulatory documents.
Combination safety depends on mechanisms and your health profile. Use our interactions checker and always consult your doctor or pharmacist before combining medications.
Both drugs are approved when used per label. Safety is patient-specific — the better choice depends on your condition, other medications, allergies, and comorbidities. Consult a healthcare professional for personalized advice.
Ushbu ma'lumotlar faqat ta'lim maqsadida taqdim etilgan. U tibbiy maslahat sifatida mo'ljallanmagan. Har doim malakali tibbiyot mutaxassisiga murojaat qiling.